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Abstract
Current accepted cerebrovascular reactivity indices suffer from the need of high frequency data capture and export for post-
acquisition processing. The role for minute-by-minute data in cerebrovascular reactivity monitoring remains uncertain. 
The goal was to explore the statistical time-series relationships between intra-cranial pressure (ICP), mean arterial pressure 
(MAP) and pressure reactivity index (PRx) using both 10-s and minute data update frequency in TBI. Prospective data from 
31 patients from 3 centers with moderate/severe TBI and high-frequency archived physiology were reviewed. Both 10-s by 
10-s and minute-by-minute mean values were derived for ICP and MAP for each patient. Similarly, PRx was derived using 
30 consecutive 10-s data points, updated every minute. While long-PRx (L-PRx) was derived via similar methodology using 
minute-by-minute data, with L-PRx derived using various window lengths (5, 10, 20, 30, 40, and 60 min; denoted L-PRx_5, 
etc.). Time-series autoregressive integrative moving average (ARIMA) and vector autoregressive integrative moving aver-
age (VARIMA) models were created to analyze the relationship of these parameters over time. ARIMA modelling, Granger 
causality testing and VARIMA impulse response function (IRF) plotting demonstrated that similar information is carried in 
minute mean ICP and MAP data, compared to 10-s mean slow-wave ICP and MAP data. Shorter window L-PRx variants, 
such as L-PRx_5, appear to have a similar ARIMA structure, have a linear association with PRx and display moderate-to-
strong correlations (r ~ 0.700, p < 0.0001 for each patient). Thus, these particular L-PRx variants appear closest in nature to 
standard PRx. ICP and MAP derived via 10-s or minute based averaging display similar statistical time-series structure and 
co-variance patterns. PRx and L-PRx based on shorter windows also behave similarly over time. These results imply certain 
L-PRx variants may carry similar information to PRx in TBI.
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1 Introduction
Cerebrovascular reactivity monitoring in adult traumatic 
brain injury (TBI) is becoming increasingly common in the 
critical care management of moderate and severe TBI [1, 2]. 
Impaired cerebrovascular reactivity has been linked to worse 
global outcome in adult TBI at 6 months [3–6], and appears 
independent of current intensive care unit (ICU) therapies 
for TBI [7, 8].
Various metrics for continuous monitoring of cerebro-
vascular reactivity have been described in adult TBI, based 
on the invasive/non-invasive modalities employed for moni-
toring cranial physiology. The intra-cranial pressure (ICP) 
based measures have received the most attention, with the 
pressure reactivity index (PRx) considered the standard by 
many [9]. PRx is one of the few indices with some experi-
mental literature to support its ability to detect the lower 
limit of autoregulation during both arterial hypotension and 
intra-cranial hypertension [10–12]. Furthermore, impaired 
vascular reactivity, as measured through PRx, has an exten-
sive body of literature supporting its association with poor 
global outcome [4, 5], cerebral metabolic dysfunction [13, 
14] and impaired cerebral oxygen delivery [9, 15].
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However, despite the promising nature of PRx, it has 
limitations. One important limitation is the data required for 
derivation. PRx is based on the concept that the correlation 
between slow-wave vasogenic fluctuations in a measure of 
cerebral blood volume (such as ICP) and a driver of cerebral 
blood flow (such as mean arterial pressure (MAP)), pro-
vide a surrogate measure of cerebral autoregulation [3]. As 
such, the calculation of standard PRx requires 10-s by 10-s 
mean values of ICP and MAP, focusing on the slow-wave 
frequency range of 0.05–0.005 Hz. [16, 17] Most bedside 
monitors in the ICU employed globally struggle to provide 
data export at such a frequency, with most providing minute-
by-minute data as their highest export frequency. As such, 
PRx has classically required third party software, and in 
many cases data up-sampling, to be calculated and properly 
assessed.
Given this, there has been an attempt to utilize minute-
by-minute ICP and MAP data to derive low resolution, or 
low frequency, versions of PRx, termed long-PRx (L-PRx), 
with the aim to increase accessibility to such monitoring 
[18–20]. Such measures have shown moderate correlation 
with standard PRx, and an association with global outcome 
in adult TBI, in small populations, and likely capture the 
low-frequency end of the vasogenic frequency range.
Despite this, there exists uncertainty as to whether min-
ute-by-minute ICP and MAP data behave similarly to higher 
frequency 10-s mean data, and whether L-PRx carries simi-
lar information to PRx over time. Previous works focused 
mainly on the correlation between large averaged time 
periods of data, not focusing on the statistical properties of 
the parent signals. In the absence of a direct gold standard 
reproducible measure of autoregulation or cerebral blood 
flow in vivo, we cannot directly compare measures such as 
PRx and L-PRx to flow or vascular regulation. Thus, we are 
left with exploring the relationships of these derived signals, 
their structure statistically and behavior over time, in order 
to make more definitive comments as to whether L-PRx 
metrics provide close surrogate measure of PRx and may be 
employed clinically. As such, the goal of this study was to 
evaluate the statistical time-series relationships between ICP, 
MAP and PRx/L-PRx using both data derived from 10-s and 
minute-based means of ICP and MAP in adult TBI.
2  Methods
2.1  Patients
Patient data was accrued retrospectively from three cent-
ers with archived high resolution physiologic data, 
with two from Nordic countries (Helsinki University 
Hospital,Helsinki, Finland, and the Karolinska Univer-
sity Hospital, Stockholm, Sweden), and one from Canada 
(Winnipeg Health Sciences Centre). All patients were stud-
ied during January 2015 to February 2019. All patients from 
Stockholm and Helsinki were also part the multi-center Col-
laborative European Neuro Trauma Effectiveness Research 
in TBI (CENTER-TBI) study high-resolution ICU sub-study 
cohort [21]. These patients were prospectively recruited dur-
ing the periods of January 2015 to December 2017. Patients 
from Winnipeg were studied as part of an ongoing prospec-
tive high-resolution TBI database, started in early 2018.
All patients suffered predominantly from moderate to 
severe TBI (moderate = Glasgow Coma Score (GCS) 9–12, 
and severe = GCS of 8 or less). A minority of patients suf-
fered from mild TBI (GCS 13-15), with subsequent early 
deterioration leading to ICU admission for care and monitor-
ing. All patients in this cohort had invasive ICP monitoring 
conducted in accordance with the BTF guidelines [22].
2.2  Ethics
Data from Stockholm and Helsinki were collected as part 
of the CENTER-TBI study which had individual national 
or local regulatory approval ((Stockholm 2014-11473-31/4, 
Helsinki 21.10.2014, Dnro ETMK: 95/1801/2014). The 
CENTER-TBI study (EC grant 602150) has been conducted 
in accordance with all relevant laws of the EU if directly 
applicable or of direct effect and all relevant laws of the 
country where the Recruiting sites were located, including 
but not limited to, the relevant privacy and data protection 
laws and regulations (the “Privacy Law”), the relevant laws 
and regulations on the use of human materials, and all rel-
evant guidance relating to clinical studies from time to time 
in force including, but not limited to, the ICH Harmonised 
Tripartite Guideline for Good Clinical Practice (CPMP/
ICH/135/95) (“ICH GCP”) and the World Medical Asso-
ciation Declaration of Helsinki entitled “Ethical Principles 
for Medical Research Involving Human Subjects”. Informed 
Consent by the patients and/or the legal representative/next 
of kin was obtained, accordingly to the local legislations, for 
all patients recruited in the Core Dataset of CENTER-TBI 
and documented in the e-CRF.
Data from the Winnipeg cohort was collected in accord-
ance with full local health research ethics board approval 
from the University of Manitoba (H2017:181, H2017:188, 
and H2019:157).
2.3  Data collection
All patients had demographics prospectively recorded. Simi-
larly, all patients had high frequency digital signals from 
ICU monitoring recorded throughout their ICU stay, with 
the goal of initiating recording within 24 h of ICU admis-
sion. All digital ICU signals were further processed (see 
Signal Acquisition/Signal Processing). For the purpose of 
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this study, the following admission demographic variables 
were retrospectively collected: age, sex, admission Glasgow 
Coma Scale (GCS—total and motor) and admission pupil-
lary response (bilaterally reactive, unilateral reactive, bilat-
eral unreactive). CENTER-TBI data was accessed/extracted 
using Opal database software [23] for the Stockholm and 
Helsinki data.
2.4  Signal acquisition
Arterial blood pressure (ABP) was obtained through either 
radial or femoral arterial lines connected to pressure trans-
ducers (Baxter Healthcare Corp. CardioVascular Group, 
Irvine, CA, or similar devices). ICP was acquired via an 
intra-parenchymal strain gauge probe (Codman ICP Micro-
Sensor; Codman & Shurtleff Inc., Raynham, MA), paren-
chymal fiber optic pressure sensor (Camino ICP Monitor, 
Integra Life Sciences, Plainsboro, NJ, United States; https 
://www.integ ralif e.com/) or external ventricular drain (in 
3 patients). All signals were recorded using digital data 
transfer or digitized via an A/D converter (DT9801; Data 
Translation, Marlboro, MA), where appropriate, sampled at 
frequency of 100 Hertz (Hz) or higher, using the ICM + soft-
ware (Cambridge Enterprise Ltd, Cambridge, UK, http://
icmpl us.neuro surg.cam.ac.uk) or Moberg CNS Monitor 
(Moberg Research Inc, Ambler, PA, USA) or a combina-
tion of both. Signal artifacts were removed using both man-
ual and automated methods prior to further processing or 
analysis.
2.5  Signal processing
Post-acquisition processing of the above signals was con-
ducted using ICM + . Only the acute ICU physiology was 
utilized for this study (i.e. the first 5 days after injury). For 
ICP and MAP, two sets of data were produced. First, 10-s 
moving averages (updated every 10 s to avoid data over-
lap) were calculated for all recorded signals: ICP and ABP 
(which produced MAP). Second, minute-by-minute averages 
were also created for both ICP and MAP.
Next, we derived PRx and L-PRx variants for each 
patient. PRx was derived via the moving correlation coef-
ficient between 30 consecutive 10 s mean windows of the 
parent signals (ICP and MAP), updated every minute. This 
methodology for PRx determination has been employed for 
over 20 years, with this metric having been preliminarily 
validated as a measure of the lower limit of autoregulation in 
experimental animal models [3]. Finally, L-PRx was derived 
using minute-by-minute mean values of ICP and MAP, with 
various window lengths for calculation, updated every min-
ute. The window lengths used for L-PRx were: 5, 10, 20, 
30, 40 and 60 min windows. This created the following 
respective L-PRx variants: L-PRx_5, L-PRx_10, L-PRx_20, 
L-PRx_30, L-PRx_40, and L-PRx_60; based on previous 
literature on low-frequency PRx variants in TBI [18–20].
2.6  Statistics
All statistical analysis were conducted using R (R Core 
Team (2016). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, 
Austria. URL https ://www.R-proje ct.org/) and XLSTAT 
(Addinsoft, New York, NY; https ://www.xlsta t.com/en/) 
add-on package to Microsoft Excel (Microsoft Office 15, 
Version 16.0.7369.1323).
For all testing described within, the alpha was set at 
0.05 for significance. Given the bounded nature of PRx 
and L-PRx variables, all cerebrovascular reactivity indices 
were transformed using a Fisher natural logarithmic trans-
formation. Thus, for all reference to PRx and L-PRx within 
the manuscript, we are referring to the Fisher transformed 
indices. Similarly, ICP and MAP were transformed using 
a logarithmic transformation, and for all reference to ICP 
and MAP within the manuscript we are referring to log10 
transformed values.
We currently lack a direct, reliable and reproducible 
continuous measure of cerebral autoregulation and cerebral 
blood flow in vivo in humans. As such, previous studies 
have tried to validate PRx against the Lassen curve [24], in 
particular the lower limit of autoregulation, in experimental 
animal models [10–12]. To date, PRx has the largest sup-
porting evidence as a continuous metric of cerebrovascular 
reactivity in adult TBI. To validate L-PRx, in the absence of 
human or animal studies evaluating it against the autoregu-
latory curve, we must rely on its relationship and behav-
ior with respect to PRx. Doing so requires evaluating the 
derived signal structures of PRx and L-PRx variants over 
time statistically, using various time series methodologies 
(see sub-sections to follow). In theory, if the structure and 
behavior of L-PRx is similar to PRx, then one could say that 
L-PRx may provide similar information to PRx. Studies like 
this may provide preliminary support for the use of L-PRx 
clinically in TBI.
2.7  ICP and MAP analysis
ICP and MAP were analyzed in both 10-s by 10-s and minute-
by-minute mean value data sheets, per patient. The time series 
characteristics of ICP and MAP were independently evaluated 
in each patient, using Box-Jenkin’s autoregressive integrative 
moving average (ARIMA) models [25–27]. First, both ICP 
and MAP were evaluated for time stationarity and trend using: 
autocorrelation function (ACF) plots, partial autocorrelation 
function (PACF) plots, augmented Dickey-Fuller (ADF) test 
for root trend, and the Kwiatkowski–Phillips–Schmidt–Shin 
(KPSS) test for trend. All tests confirmed non-stationary ICP 
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and MAP time-series in each patient. As such, a first order 
differencing was introduced to each, and the above-mentioned 
tests repeated to demonstrate stationary behavior.
Next, the optimal ARIMA structure for ICP and MAP were 
derived in both the 10-s and minute mean data sheets, for each 
patient. The auto.arima function was initially employed to 
determine the upper order limit for tested ARIMA models. 
Based on this, autoregressive order (p) was varied from 1 to 
4, and the moving average order (q) was varied from 1 to 4, 
while the integrative order (d) was held at 1. All subsequent 
permutations of the ARIMA orders were assessed, with the 
model Akaike Information Criterion (AIC) and Log-Likeli-
hood (LL) recorded for every model, for both ICP and MAP, 
in every patient. Using the AIC and LL, the optimal ARIMA 
structures for ICP and MAP variables were compared in the 
10-s and minute mean data sheets, with the lowest AIC and 
highest LL values indicating superior models. As an exam-
ple, the general Box-Jenkin’s ARMA model for ICP can be 
expressed as follows:
where: c = constant, t = time “t”, i = integer, j = integer, 
p = autoregressive order, ICP = intra-cranial pressure, 
q = moving average order,  θ = autoregressive coefficient 
at time “t–i”,  ϕ  = moving average coefficient at time 
“t–j”,  = error term.
Subsequently, the influence of ICP and MAP on one 
another over time was assessed via Granger causality using 
stationary first order difference ICP and MAP data, with both 
the impact of ICP on MAP, and the impact of MAP on ICP 
tested. This was tested in both the 10-s and minute mean data 
sheets, for every patient. Both F-test statistic value and p-val-
ues were recorded.
Finally, in order to further evaluate if 10-s or minute based 
mean data made a difference in the behavior of ICP and MAP 
over time, we derived multi-variate vector ARIMA (VAR-
IMA) models. Such models explore the behavior of two time 
series recorded simultaneously over time, and are derived via 
extending the standard Box-Jenkin’s models to multi-variate 
systems [25, 27, 28]. Further description on this technique can 
be found in the references. The vector autoregressive moving 
average model (VARMA) of first order difference ICP and 
MAP can be represented by the following formula:
where: C = constant vector, t = time “t”, i = integer, 
j = integer, p = VARMA autoregressive order, Y = ICP 
and MAP vector, q = VARMA moving average order, 














A = autoregressive coefficient matrix at “t–i”, B = mov-
ing average coefficient matrix at time “t–j”, E = error term 
vector.
We utilized differenced ICP and MAP signals, to elimi-
nate trend and seasonality, and employed basic VARMA 
models with autoregressive order of 4 and moving average 
order of 4, based on the findings from individual patient 
ARIMA models of ICP and MAP, for both the 10-s and 
minute mean based data, for each patient. The VARMA 
model autoregressive order of 4 was chosen given the opti-
mal ARIMA models for ICP and MAP in most patients had 
autoregressive orders of 2, and thus the product of these 
orders is 4. Taking the product of the ARIMA autoregressive 
orders for VARMA modelling is one suggested method of 
ensuring adequate model structure to cover such a multi-
variate time series [27]. Similarly, the moving average order 
for the VARMA model was based on the sum of the optimal 
moving average orders from the ARIMA modelling [27] of 
ICP and MAP, with an order of 2 being the most commonly 
displayed optimal order for ICP and MAP. Given this was 
a pilot exploratory analysis, this general (4,1,4) VARIMA 
model structure was employed for each patient. The coef-
ficients derived from these VARMA models were then 
employed to derive impulse response function (IRF) plots 
between ICP and MAP. The IRF plots provide a descrip-
tive graphical representation of the impact of ICP on MAP, 
and MAP on ICP, by using the generated VARIMA model 
and modelling a one unit orthogonal impulse of one vari-
able on the other, and vice versa [27]. The plots depict how 
much from baseline one variable fluctuates in response to 
the orthogonal impulse of the other variable, and how many 
lags in time it takes to recover back to baseline.
2.8  PRx and L‑PRx analysis
Using minute-by-minute updated PRx and L-PRx data, the 
following analysis was conducted. For each patient, locally 
weighted scatterplot smoothing (LOESS) function plots 
were created between PRx and each L-PRx variant, assess-
ing the degree of linearity between each L-PRx metric and 
the conventional PRx. Next, Pearson correlation coefficients 
between PRx and L-PRx were determined for each patient, 
for each variant of L-PRx. Of note, the degree of statistical 
significance of the linear models and Pearson correlation 
coefficients are artificially increased secondary to autocor-
relation between minute-by-minute updated measures, and 
violation of the pre-conditions of linearity. As such, both the 
linear model plots and correlation coefficients reported are 
for purely descriptive purposes only, and the size of the p 
value or nature of the confidence intervals should be inter-
preted with caution.
Finally, the optimal ARIMA time-series structure 
was compared for PRx and all L-PRx variants for each 
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individual patient using the following methodology. First, 
ACF and PACF plots were produced, and both ADF and 
KPSS testing were conducted, for all PRx/L-PRx meas-
ures, confirming non-stationarity. First order differenc-
ing was then undertaken to remove all trend components, 
confirming stationarity by repeating the above-mentioned 
plots and testing. Next ARIMA models were built for each 
PRx and L-PRx variable, keeping the differencing order of 
1 (i.e. d = 1), and varying both the autoregressive and mov-
ing average orders (i.e. p and q, respectively) from 0 to 4, 
through all respective permutations. The AIC and LL were 
then tabulated for each of these models, for every patient. 
Using the AIC and LL, the optimal ARIMA structures for 
PRx and L-PRx variables were compared, with the lowest 
AIC and highest LL values indicating superior models.
2.9  Outcome analysis
We briefly evaluated the association with outcome for 
PRx and the derived L-PRx metrics. Employing univariate 
logistic regression, we assessed the association between 
PRx and L-PRx measures to dichotomized Glasgow Out-
come Scale Extended (GOSE) at 6 months post-injury. 
We evaluated both mortality and favourable/unfavour-
able outcome (defined as GOSE 5 or above for favour-
able outcome). Models were assessed by area under the 
receiver operating curve (AUC), Akaike Information Cri-
terion (AIC) and 95% confidence intervals (95% CI), with 
alpha set at 0.05 for significance. AUC and 95% CI were 
determined through a bootstrap resampling methodology, 
employing 2000 iterations.
3  Results
3.1  Patient demographics
A total of 31 patients from the three centers were included 
in this study. The mean age was 41.7 ± 13.6 years, with 23 
(74.2%) male. The median admission total GCS score and 
motor sub-scores were 6 (IQR: 3 to 8) and 4 (IQR: 1 to 
5), respectively. Three patients (9.7%) suffered pre-hospital 
hypoxic episodes, and three (9.7%) suffered hypotension epi-
sodes. Ten patients (32.3%) presented with bilaterally unre-
active pupils, and one (3.2%) with unilaterally unreactive 
pupils. The mean duration of high frequency digital signal 
recording was 108.3 ± 50.7 h. Table 1 displays the patient 
admission demographics and injury information. Figure 1 
displays a patient example of PRx and some L-PRx variants 
over time, highlighting the loss of information with larger 
L-PRx window lengths.
3.2  ICP and MAP analysis—ARIMA structure
We evaluated the ARIMA time-series structure for both ICP 
and MAP, in every patient, using log transformed and first 
order differenced data (of note, this transformed and dif-
ferenced data was utilized for all parts of the ICP and MAP 
analysis). This was conducted in both 10-s and minute mean 
data. Table 4 displays a patient example of the AIC and LL 
for each ARIMA model tested, in both data sheets. In gen-
eral, the optimal ARIMA structure for ICP and MAP varied 
between patients, given inter-patient heterogeneities. How-
ever, comparing the ARIMA structures of ICP and MAP 
between the 10-s and minute averaged data, there was no 
substantial difference in the optimal ARIMA models. This 
suggests that the time-series behavior is similar for 10-s 
average vasogenic slow-wave ICP and MAP data, compared 
to minute-by-minute ICP and MAP data.
3.3  ICP and MAP analysis—granger causality
In order to further assess for differences between 10-s and 
minute mean data for ICP and MAP (transformed and dif-
ferenced), we performed Granger causality testing in both 
sets of data for all individual patients. For most patients, the 
directional nature of the causal relationship regardless of 
whether 10-s or minute mean data were assessed, favored 
MAP impacting ICP. A small minority of patients displayed 
the alternative causal relationship. Table 2 provides the 
Granger test results, including F-test and p values, for every 
patient. Of note, the causal direction of the ICP and MAP 
relationship was unchanged, regardless of testing on 10-s 
or minute mean data. This suggests that minute-by-minute 
mean data does not lose information regarding the ICP and 
MAP relationship, which is seen in 10-s vasogenic slow-
wave data.
3.4  ICP and MAP analysis—VARMA and impulse 
response
Finally, to assess the relationship between ICP and MAP 
further, and whether there was a difference in information 
carried between 10-s and minute mean data, we employed 
VARIMA modelling. VARIMA models of autoregressive 
order 4, integrative order 1, and moving average order 4 
were employed for each individual patient, for both the 10-s 
and minute mean data. IRF plots were produced to provide 
a descriptive visualization of the relationship between ICP 
and MAP, in both data sets. These IRF plots allowed us to 
visually determine the relationship between ICP and MAP, 
assessing the impact of one unit impulse in MAP on ICP, 
using transformed data.
Overall, using minute mean data led to similar absolute 
changes in the ICP standard error, with some blunting of 
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the response of ICP to the impulse in MAP, likely related 
to the data smoothing seen in the minute mean data. This 
was seen in all patients, and confirms that some informa-
tion regarding the slow-wave relationship between ICP and 
MAP is lost in the minute mean data, however there is 
preservation of the overall general shape of response of 
ICP to changes in MAP. This, suggests that the minute 
mean data does indeed contain some information regard-
ing cerebrovascular reactivity. Figure 2 displays the IRF 
plots for two patient examples, highlighting the similar 
ICP response to a MAP impulse.
3.5  PRx and L‑PRx variants—linear relationships
For each individual patient the linear relationship between 
PRx and L-PRx variants was assessed using LOESS plots, 
Pearson correlations and Bland–Altman Analysis. Table 3 
provides the Pearson correlation between PRx and the 
L-PRx variants for every patient. Overall, PRx was most 
closely associated with L-PRx_5, with the highest Pearson 
correlation values (~ 0.700, p < 0.0001 for all patients) and 
visually the strongest linear relationship on LOESS analysis. 
Similarly, Bland–Altman analysis confirmed in every patient 
Table 1  Admission patient 
demographics and CT 
characteristics—median, IQR 
and raw numbers
a.u. arbitrary units, CPP cerebral perfusion pressure, CT computed tomography, GCS glasgow coma score, 
GOSE glasgow outcome score, ICP intra-cranial pressure, IQR inter-quartile range, IVH intra-ventricular 
hemorrhage, MAP mean arterial pressure, mm millimetres, mmHg millimetres of mercury, PRx pressure 
reactivity index (correlation between slow-waves in ICP and MAP), L-PRx correlation between ICP and 
MAP using min-by-min average data (the number after L-PRx indicates the calculation window length in 
minutes), SAH subarachnoid hemorrhage
Median (IQR) or raw number
Number of patients 31
Age (years) 43 (30–55)
Sex Male 23
Female 8
Duration of high frequency physiologic recording (hours) 120.4 (69.2–138.0)
Admission GCS (total) 6 (3–8)
Admission GCS motor 4 (1–5)
Number with hypoxia episode 3
Number with hypotension episode 3
Admission pupil response Bilaterally reactive 20
Unilateral unreactive 1
Bilaterally unreactive 10






Number with traumatic SAH 25
Number with epidural hematoma 6
Mean ICP (mmHg) 13.0 (10.8–15.3)
MAP (mmHg) 81.6 (74.7–89.3)
Mean CPP (mmHg) 64.0 (61.6–73.2)
Mean PRx (a.u.) − 0.052 (− 0.140 to 0.100)
Mean L-PRx_5 − 0.108 (− 0.218 to 0.003)
Mean L-PRx_10 − 0.122 (− 0.221 to 0.028)
Mean L-PRx_20 − 0.098 (− 0.179 to 0.064)
Mean L-PRx_30 − 0.067 (− 0.147 to 0.098)
Mean L-PRx_40 − 0.064 (− 0.120 to 0.100)
Mean L-PRx_60 − 0.021 (− 0.093 to 0.140)
GOSE at 6 months 4 (3–5)
Number dead at 6 months 5
Number unfavrourable outcome at 6 months 16
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to display a consistent overestimation bias of L-PRx_5. All 
other L-PRx variants performed poorly in comparison to 
standard PRx. Figure 3 displays a patient example of LOESS 
and Bland–Altman plots for PRx versus L-PRx_5, and PRx 
versus L-PRx_30.
3.6  PRx and L‑PRx variants—ARIMA structure
Finally, the ARIMA time-series structure for PRx and 
L-PRx variants were assessed in each patient. Table 5 
provides some patient examples of the ARIMA analysis, 
documenting the ARIMA model, AIC and LL. As with ICP 
and MAP testing, the optimal ARIMA model for PRx and 
L-PRx variants, was patient dependent. However, in general, 
PRx and the small window length versions of L-PRx (i.e. 
L-PRx_5 and L-PRx_10) had similar ARIMA structures 
within any individual patient. L-PRx variants with larger 
window lengths for calculation were increasingly dissimilar 
to standard PRx based on optimal ARIMA structure, as seen 
in every patient.
3.7  Outcome association
We performed univariate logistic regression analysis between 
mean PRx and L-PRx metrics with dichotomized GOSE at 
6 months. In keeping with other studies, these PRx/L-PRx 
metrics displayed stronger association with mortality than 
favourable/unfavourable outcome [18–20]. The AUC for all 
PRx and L-PRx measures were not statistically different, 
with large overlapping 95% CI’s, consistent with such a small 
cohort. However, despite the limited conclusions that can be 
made, we can say that the L-PRx metrics display statistically 
significant associations with mortality at 6 months, as does 
PRx. All metrics failed to display a significant association 
with favourble/unfavourable outcome at 6 months. Table 6 
provides a tabulated summary of the AUC, 95% CI and AIC 
values for the univariate logistic regression analysis.
4  Discussion
Given the absence of direct, reliable and reproducible metrics 
of cerebral autoregulation and cerebral blood flow in vivo in 
adult TBI, to evaluate whether L-PRx is similar to PRx, we 
must rely on investigating the statistical relationships between 
high-frequency fluctuations in the derived signals. To do so 
requires evaluating such behavior over time between both the 
parent signals used to derive PRx and L-PRx, and also the 
relationship between PRx and L-PRx metrics themselves. 
As such, we employed complex time-series analyses via 
ARIMA, VARMA and Granger causality testing. Through in-
depth evaluation of the relationship between ICP and MAP, 
using 10-s and minute based mean data, and comparing 
standard PRx to L-PRx variants, some important insights into 
lower resolution cerebrovascular reactivity metrics have been 
made. This provides some preliminary evidence to support 
that certain L-PRx metrics may be considered to be applied 
clinically in TBI monitoring, after further prospective inves-
tigation. Further, these results carry implications to expand 
the application of cerebrovascular reactivity monitoring, 
through low-frequency L-PRx metrics, to centers without 
biomedical signal processing expertise or ability to capture 
high-frequency full waveform physiology.
First, minute based mean ICP and MAP data displays 
similar time-series relationships, Granger causality and IRF 
Fig. 1  PRx and L-PRx variant behaviour over time—patient example. 
ICP intra-cranial pressure, MAP mean arterial pressure, PRx pressure 
reactivity index (correlation between ICP and MAP), L-PRx_5 cor-
relation between minute based ICP and MAP (5-min window length), 
L-PRx_20 correlation between minute based ICP and MAP (20-min 
window length), L-PRx_60 correlation between minute based ICP 
and MAP (60-min window length). Longer window lengths leads to 
further data smoothing for L-PRx and loss of signal variance in time
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plots, compared to the conventional 10-s averaged vasogenic 
slow-wave ICP and MAP data. This is important because 
despite the smoothing effect seen with minute based ICP 
and MAP data, and concerns about only capturing the ultra-
low end of the vasogenic slow-wave frequency spectrum 
(i.e. 0.005 Hz or less), minute based data appears to still 
carry some information regarding the ICP and MAP rela-
tionship seen in the higher frequency 10-s data set. This 
implies that minute based ICP and MAP data may carry 
information regarding cerebrovascular reactivity, supporting 
their use in the derivation of L-PRx measures. Though we 
must acknowledge, the results found in this manuscript are 
preliminary and require much further validation.
Second, despite both the Granger testing and VARIMA 
IRF plots indicating that the minute based data likely car-
ries some information regarding cerebrovascular reactivity 
from the ultra-low end of the vasogenic slow-wave frequency 
range, there are some subtle findings that also suggest this 
data carries other potential information. The magnitude of the 
Granger F-test statistic decreased for the MAP on ICP causal 
relationship, when evaluating the minute based data, with 
two patients falling out of significance for this relationship. 
Table 2  Granger testing for 10-s and minute mean data of ICP and MAP—each patient
Table displays Granger causality testing for MAP on ICP and ICP on MAP, using 10-s and minute mean data sets. The larger F-test value indi-
cates which direction is favored in the relationship between two variables. In general, the directional nature of causality favors MAP on ICP, 
using both the 10-s and minute mean data
ICP intra-cranial pressure, MAP mean arterial pressure
Patient 10-s mean data Minute mean data
Granger test: MAP on ICP Granger test: ICP on MAP Granger test: MAP on ICP Granger test: ICP on MAP
F-test value P-value F-test value P-value F-test value P-value F-test value P-value
1 7.325688 P < 0.0001 1.747827 0.13637 7.821262 P < 0.0001 5.854906 0.0001
2 196.5859 P < 0.0001 352.1715 P < 0.0001 9.799218 P < 0.0001 66.01506 P < 0.0001
3 184.9533 P < 0.0001 154.9658 P < 0.0001 7.237617 P < 0.0001 1.699532 0.1480
4 1189.339 P < 0.0001 71.14927 P < 0.0001 100.9624 P < 0.0001 35.47658 P < 0.0001
5 818.9046 P < 0.0001 26.45915 P < 0.0001 34.82038 P < 0.0001 5.414004 0.0002
6 812.6522 P < 0.0001 15.72204 P < 0.0001 4.866256 0.0006 1.214182 0.3024
7 258.3201 P < 0.0001 138.3555 P < 0.0001 4.087783 0.0026 61.22348 P < 0.0001
8 172.6672 P < 0.0001 28.3907 P < 0.0001 37.7531 P < 0.0001 8.736965 P < 0.0001
9 642.1818 P < 0.0001 186.28 P < 0.0001 32.91065 P < 0.0001 6.869269 P < 0.0001
10 384.2702 P < 0.0001 105.4163 P < 0.0001 13.43864 P < 0.0001 26.45632 P < 0.0001
11 236.045 P < 0.0001 115.1936 P < 0.0001 24.51224 P < 0.0001 3.411614 0.0086
12 20.88989 P < 0.0001 23.59018 P < 0.0001 2.348149 0.0526 6.360937 P < 0.0001
13 578.186 P < 0.0001 19.58322 P < 0.0001 7.868772 P < 0.0001 4.15957 0.0023
14 800.0953 P < 0.0001 80.899 P < 0.0001 22.39293 P < 0.0001 4.650688 0.0010
15 249.1448 P < 0.0001 116.2926 P < 0.0001 23.60508 P < 0.0001 8.69085 P < 0.0001
16 531.3783 P < 0.0001 135.6271 P < 0.0001 37.61616 P < 0.0001 3.210749 0.0121
17 968.5263 P < 0.0001 35.87097 P < 0.0001 27.68981 P < 0.0001 3.218454 0.0120
18 114.6648 P < 0.0001 22.43942 P < 0.0001 2.586889 0.0352 1.739461 0.1385
19 3.201506 0.0123 16.05543 P < 0.0001 3.984857 0.0033 1.295173 0.2703
20 91.71564 P < 0.0001 160.2726 P < 0.0001 64.00512 P < 0.0001 75.05347 P < 0.0001
21 148.4782 P < 0.0001 39.81235 P < 0.0001 25.25603 P < 0.0001 17.93121 P < 0.0001
22 85.3137 P < 0.0001 16.24744 P < 0.0001 5.1636 0.0004 17.6889 P < 0.0001
23 1936.034 P < 0.0001 86.56561 P < 0.0001 86.15334 P < 0.0001 9.481133 P < 0.0001
24 596.9424 P < 0.0001 87.43785 P < 0.0001 94.85877 P < 0.0001 3.510931 0.0072
25 96.15071 P < 0.0001 43.77806 P < 0.0001 0.949273 0.4342 4.668226 0.0009
26 862.1427 P < 0.0001 34.35032 P < 0.0001 7.996847 P < 0.0001 54.21212 P < 0.0001
27 126.9935 P < 0.0001 7.208399 P < 0.0001 47.36374 P < 0.0001 17.70014 P < 0.0001
28 247.8369 P < 0.0001 17.96821 P < 0.0001 11.54719 P < 0.0001 1.151579 0.3302
29 226.7049 P < 0.0001 85.50865 P < 0.0001 7.976345 P < 0.0001 10.67541 P < 0.0001
30 1410.132 P < 0.0001 76.97432 P < 0.0001 72.90067 P < 0.0001 8.287524 P < 0.0001
31 1242.374 P < 0.0001 59.30911 P < 0.0001 15.94597 P < 0.0001 2.337457 0.0534
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Thus, despite the causal direction between ICP and MAP 
remaining in favor of MAP on ICP, when going from 10-s to 
minute-based data, there is suggestion that this relationship is 
less strong. This likely stems from the fact that minute-based 
data captures information on the MAP and ICP relationship 
outside of the ultra-low end of the vasogenic slow-wave fre-
quency range associated with cerebral autoregulation [16, 
17]. Similarly, the IRF plots for MAP on ICP also hint that 
there is information regarding the relationship of MAP on 
ICP that extends beyond the vasogenic range. This is high-
lighted by the ICP response to MAP in the IRF plots taking 
on the order of minutes to return to baseline in minute based 
data, where the 10-s data returns to baseline after a min-
ute or two. However, even though these results suggest that 
minute-based data carries additional low-frequency informa-
tion regarding the MAP and ICP relationship, beyond the 
ultra-low end of the vasogenic slow-wave frequency range 
(i.e. 0.005 Hz), it is unclear at this time what this represents. 
Much further work is required in this area.
Third, L-PRx variants display heterogeneous relationships 
with standard PRx. This is in parallel to previous retrospec-
tive analysis on low frequency cerebrovascular reactivity 
metrics derived from minute-by-minute data [19]. Based on 
Pearson correlation, the correlation between standard PRx and 
L-PRx_5 was moderate to strong, with coefficients around 
0.7–0.8 for most patients in this cohort. The lack of stronger 
correlation may be related to deriving the Pearson value on 5 
paired measures of ICP and MAP for L-PRx_5. However, of 
importance is the stronger relationship between L-PRx metrics 
based on short window durations with standard PRx. This was 
seen in the ARIMA time-series analysis and both LOESS and 
correlation testing. This implies that if one were to use L-PRx 
as a measure of cerebrovascular reactivity, that shorter window 
lengths for calculation should be used, as opposed to the longer 
windows which appear to have little association with PRx 
derived from 10-s mean slow-wave data. This should not be a 
complete surprise, as longer window lengths for L-PRx cal-
culation utilize longer periods of data recording than standard 
Fig. 2  VARIMA impulse response function plots of MAP acting on 
ICP—two patient examples. ICP intra-cranial pressure, lag previous 
measure in time (× 10-s = means 1 lag is 10-s in time; x min = means 
1 lag is 1  min in time), MAP mean arterial pressure, VARIMA vec-
tor autoregressive integrative moving average models (for all patients 
autoregressive order was 4, integrative order 1, and moving average 
order 4). Panel A and B = Patient 1, and Panel C and D = Patient 2. 
Plots demonstrate transformed and differenced (i.e. de-trended) min-
ute mean ICP and MAP data (Panel B and D), and 10-s mean data 
(Panel A and C). Plots display the impact of one standard deviation 
impulse in MAP on the standard error in ICP from the VARIMA 
models. Both examples highlight some smoothing in response seen 
with minute mean data, however the general response in ICP to MAP 
impulse is similar between minute and 10-s mean data
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PRx or shorter window L-PRx variants. As such, longer L-PRx 
metrics are based on increasingly different data, as the window 
length increases. The reason for including such longer vari-
ants was to highlight the substantial difference compared to 
standard PRx, as these have been evaluated as low-frequency 
cerebrovascular reactivity metrics in the past [19, 20]. Again, 
our population was small, and further investigation in larger 
cohorts is required to validate the findings here.
Fourth, it must be re-emphasized that our results do not 
absolutely confirm or refute L-PRx metrics as measures of 
cerebrovascular reactivity. We only demonstrate preliminarily 
that aspects of L-PRx derivation and specific L-PRx metrics 
may carry similar information as standard PRx. This is impor-
tant, since widespread adoption of continuous cerebrovascular 
reactivity monitoring is hindered by the equipment and exper-
tise required for high-frequency data capture and derivation of 
standard PRx based on vasogenic slow-wave frequency data. 
Our results suggest a potential role for L-PRx measures as 
a surrogate for cerebrovascular reactivity monitoring, in the 
absence of the ability to derive PRx. Our results require much 
further validation and exploration in larger adult TBI data sets, 
as well as in experimental animal models. Given the results 
of this multi-center pilot analysis, we plan on future large 
prospective data collection to explore these findings in more 
detail, integrating patient, injury and treatment characteristics.
Finally, briefly evaluating the association between PRx 
and L-PRx and 6 month dichotomized GOSE demonstrated 
corollary findings that L-PRx displays similar outcome asso-
ciation to PRx. This is in keeping with previously published 
retrospective studies [18–20]. Our results must be inter-
preted with caution however, given the small cohort size. 
This is reflected in wide 95% CI’s. As such, at this time 
Fig. 3  LOESS and Bland–Altman plots for PRx versus L-PRx_5 and 
PRx versus L-PRx_30—patient example. a.u. arbitrary units, ICP 
intra-cranial pressure, LOESS locally weighted scatterplot smoothing 
function, MAP mean arterial pressure, PRx pressure reactivity index 
(correlation between ICP and MAP), L-PRx_5 correlation between 
minute based ICP and MAP (5-min window), L-PRx_30 correlation 
between minute based ICP and MAP (30-min window)
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we cannot say one metric is superior to the other, or if the 
lack of association between PRx and L-PRx with favourable/
unfavourable outcome is true. This will require much larger 
prospective studies, which we have planned.
In summary, these results provide some support for low-
frequency physiology in the derivation and monitoring of cer-
ebrovascular reactivity in adult TBI. With further prospective 
evaluation of such metrics, L-PRx provides the ability for a 
larger number of centers globally to be able to monitor cer-
ebrovascular reactivity in their critically ill cohorts, without the 
need for specialized biomedical signal processing capabilities, 
or high-frequency digital data, which is often not available in 
many centers. The results here imply that low-frequency physi-
ology below the low end of the vasogenic slow wave spectrum 
(i.e. 0.005 Hz and below), provides at least some information 
regarding cerebrovascular reactivity. This does not mean it 
provides all, or even the most optimal, amount of informa-
tion regarding cerebrovascular reactivity in TBI. The current 
literature body supports that the optimal slow-wave frequency 
range for vascular reactivity monitoring existing between 0.05 
and 0.005 Hz, as demonstrated in animal models interrogating 
the lower-limit of autoregulation during arterial hypotension 
[16, 17]. This frequency range is what PRx, and similar met-
rics, are designed to capture. As such, when the opportunity 
to monitor cerebrovascular reactivity based on high-frequency 
physiologic data exists, this should be the goal as it provides 
the ability to use a vascular reactivity metric, such as PRx, 
which is derived in a manner to capture this frequency range. 
L-PRx should only be considered in the setting where there is 
a lack of specialized expertise to derive PRx, or there is simply 
no ability to obtain higher frequency ICP and ABP physiology. 
The latter is often the case in many centers, given limitations 
in data export options for commercially available ICU moni-
tors. These are the situations where L-PRx carries a potential 
to improve access to cerebrovascular reactivity monitoring.
5  Limitations
Despite the promising results found, there are some limita-
tions which deserve highlighting. First, this is retrospective 
analysis of prospectively collected data, in a small data 
set. As such, our findings can only be considered explora-
tory and preliminary in nature. The 31 patients were 
selected based on these being the only TBI patients from 
the 3 centers with available ICM + data for analysis. As 
such, the results here may not be generalizable to other 
TBI populations, necessitating much needed validation. 
Second, patient, injury and treatment heterogeneity could 
have influenced the physiologic signal response, and is 
something that can only be accounted for in larger pro-
spective multi-center data sets. This can be highlighted by 
the fact that 3 of the 31 patients had EVD’s. Though in 
this particular cohort there was no difference found in the 
relationship between PRx and L-PRx, compared to the non-
EVD cohort, when looking at the individual patient level, 
there exists the potential that such differences in monitor-
ing devices, and therapies given, may impact the statistical 
signal properties. As such, the results here should be inter-
preted as preliminary, requiring much further validation 
prior to widespread adoption of L-PRx for clinical moni-
toring in adult TBI. Finally, the statistical methodology 
employed was computationally tasking. Larger prospective 
studies will benefit from more robust central computing 
services in order to accomplish analysis in a timely fashion.
6  Conclusions
ICP and MAP derived via 10-s or minute based averaging 
display similar time-series statistical structure and co-var-
iance patterns. PRx and L-PRx also behave similarly over 
time, with those L-PRx indices derived from longer time-
windows displaying less association with standard PRx 
derived from higher frequency data. These results imply 
certain short window L-PRx variants may carry similar 
information to PRx in TBI.
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Table 5  Patient example—ARIMA model AIC and LL for ICP and MAP—using 10-s and minute averaged data
Comparing the optimal AIC and LL for ICP and MAP, between 10-s and minute mean data, there is no substantial difference in the time series 
structure. This pattern was found in all 31 of the patients included in this study, with this patient’s data displayed as an example
AIC akaike information criterion, ARIMA autoregressive integrative moving average, ICP intracranial pressure, MAP mean arterial pressure
ARIMA Model 10-s mean data Minute mean data
ICP AIC ICP LL MAP AIC MAP LL ICP AIC ICP LL MAP AIC MAP LL
(0,1,0) 196388.8 − 98192.4 269930.5 − 134963 39569.24 − 19782.6 71689.08 − 35842.5
(0,1,1) 196368.8 − 98181.4 265609.2 − 132802 38779.78 − 19386.9 68214.99 − 34104.5
(0,1,2) 192234.3 − 96113.1 265437.9 − 132715 38678.96 − 19335.5 68141.03 − 34066.5
(0,1,3) 190875.4 − 95432.7 265199.9 − 132595 38608.42 − 19299.2 68085.34 − 34037.7
(0,1,4) 190771.8 − 95379.9 265201.8 − 132595 38571.06 − 19279.5 68023.08 − 34005.5
(1,1,0) 196379 − 98186.5 266268.8 − 133131 38960.74 − 19477.4 69664.86 − 34829.4
(1,1,1) 192440.5 − 96216.3 265351.4 − 132672 38589.53 − 19290.8 68118.71 − 34055.4
(1,1,2) 190892.8 − 95441.4 265305 − 132647 38549.22 − 19269.6 67983.68 − 33986.8
(1,1,3) 190791 − 95389.5 265201.9 − 132595 38551.12 − 19269.6 67985.65 − 33986.8
(1,1,4) 190770 − 95378 265203.7 − 132595 38478.1 − 19232.1 67987.03 − 33986.5
(2,1,0) 193682.1 − 96837 265874.4 − 132933 38830.76 − 19411.4 68976.31 − 34484.2
(2,1,1) 190776.9 − 95383.5 265278.4 − 132634 38549.59 − 19269.8 68038.36 − 34014.2
(2,1,2) 190778.9 − 95383.4 265220.9 − 132604 38551.23 − 19269.6 67985.63 − 33986.8
(2,1,3) 190772.4 − 95379.2 265160.8 − 132573 38552.94 − 19269.5 67987.45 − 33986.7
(2,1,4) 190757 − 95370.5 265150.6 − 132567 38554.87 − 19269.4 67989.04 − 33986.5
(3,1,0) 192186.7 − 96088.3 265385.2 − 132688 38753.15 − 19371.6 68750.63 − 34370.3
(3,1,1) 190778.8 − 95383.4 265187.1 − 132588 38551.15 − 19269.6 67991.69 − 33989.8
(3,1,2) 190780.8 − 95383.4 265146.3 − 132566 38553.44 − 19269.7 67988.98 − 33987.5
(3,1,3) 190781.7 − 95382.8 265148.3 − 132566 38549.55 − 19266.8 67988.83 − 33986.4
(3,1,4) 190739.8 − 95360.9 265140.9 − 132561 38557.21 − 19269.6 67989.47 − 33985.7
(4,1,0) 191405.4 − 95696.7 265215.2 − 132602 38689.2 − 19338.6 68607.28 − 34297.6
(4,1,1) 190727.9 − 95357 265174.7 − 132580 38553.08 − 19269.5 67991.2 − 33988.6
(4,1,2) 190781.3 − 95382.7 265148.7 − 132566 38555.06 − 19269.5 67993.81 − 33988.9
(4,1,3) 190783.9 − 95383 265146.6 − 132564 38549.9 − 19265.9 67982.67 − 33982.3
(4,1,4) 190449.4 − 95214.7 265142.4 − 132561 38549.27 − 19264.6 67991.68 − 33985.8
Table 6  Univariate 
logistic regression analysis 
-cerebrovascular reactivity 
and dichotomized outcome at 
6 months
AUC and 95% CI calculated using bootstrap methodology with 2000 iterations. Bolded values indicate 
those reaching statistical significance (alpha of 0.05)
A/D alive/dead, AUC area under the receiver operating curve, CI confidence interval, F/U favourable/unfa-
vourable outcome (i.e. favourable = glasgow outcome scale of 5 to 8; unfavourable = glasgow outcome 
scale of 1 to 4), ICP intra-cranial pressure, MAP mean arterial pressure, PRx pressure reactivity index (cor-
relation between ICP and MAP)
Model AUC A/D 95% CI AIC P-value AUC F/U 95% CI AIC P-value
PRx 0.784 0.520–0.986 26.0 0.02 0.418 0.222–0.644 49.2 0.552
L-PRx_5 0.832 0.624–0.992 24.1 0.007 0.587 0.369–0.791 49.0 0.475
L-PRx_10 0.880 0.728–0.999 23.2 0.005 0.591 0.369–0.796 48.9 0.446
L-PRx_20 0.880 0.728–0.992 22.4 0.003 0.609 0.391–0.800 48.7 0.378
L-PRx_30 0.888 0.736–0.999 22.6 0.003 0.627 0.409–0.818 48.7 0.367
L-PRx_40 0.880 0.712–0.992 22.8 0.004 0.613 0.404–0.813 48.6 0.357
L-PRx_60 0.848 0.688–0.968 23.3 0.005 0.596 0.378–0.796 48.6 0.344
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